Literature DB >> 11403219

Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.

K P Tercyak1, C Lerman, B N Peshkin, C Hughes, D Main, C Isaacs, M D Schwartz.   

Abstract

Using the monitoring process model (MPM), the authors examined the immediate effects of coping style and test results on the psychological distress of women at increased risk for breast and/or ovarian cancers. Cases selected for analysis were 107 probands and relatives of positive probands participating in genetic counseling and testing for heritable cancer risk. Specifically, the authors explored the relationships among coping style (high and low monitoring), test results (BRCA1 and BRCA2 mutation carrier and noncarrier status), and psychological distress (state anxiety). Consistent with the MPM, higher monitoring was associated with greater psychological distress while anticipating genetic test results. After test results were disclosed, greater distress was associated with testing positive for a mutation. The implications of the findings for breast and ovarian cancer patients are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403219

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  29 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  The role of distress in uptake and response to predisposition genetic testing: the BMPR2 experience.

Authors:  Diana L Jones; Ellen W Clayton
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-15

Review 3.  Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer.

Authors:  J R J De Leeuw; M J van Vliet; M G E M Ausems
Journal:  Fam Cancer       Date:  2008-03-14       Impact factor: 2.375

4.  Psychological factors associated with emotional responses to receiving genetic risk information.

Authors:  Paul Bennett; Clare Wilkinson; Jim Turner; Kate Brain; Rhiannon Tudor Edwards; Gethin Griffith; Barbara France; Jonathon Gray
Journal:  J Genet Couns       Date:  2008-02-08       Impact factor: 2.537

5.  Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales.

Authors:  Nadine A Kasparian; Claire E Wakefield; Bettina Meiser
Journal:  J Genet Couns       Date:  2007-08-13       Impact factor: 2.537

6.  Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred.

Authors:  Anita Yeomans Kinney; Sara Ellis Simonsen; Bonnie Jeanne Baty; Diptasri Mandal; Susan L Neuhausen; Kate Seggar; Rich Holubkov; Ken Smith
Journal:  Am J Med Genet A       Date:  2006-04-15       Impact factor: 2.802

7.  Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment.

Authors:  Paul Bennett; Clare Wilkinson; Jim Turner; Rhiannon Tudor Edwards; Barbara France; Gethin Griffith; Gethin Griffin; Jonathon Gray
Journal:  Fam Cancer       Date:  2008-11-15       Impact factor: 2.375

8.  Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population.

Authors:  Michel Dorval; Karine Bouchard; Elizabeth Maunsell; Marie Plante; Jocelyne Chiquette; Stéphanie Camden; Michel J Dugas; Jacques Simard
Journal:  J Genet Couns       Date:  2008-05-15       Impact factor: 2.537

9.  Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.

Authors:  Kenneth P Tercyak; Tiffani A Demarco; Bryn D Mars; Beth N Peshkin
Journal:  Am J Med Genet A       Date:  2004-11-15       Impact factor: 2.802

10.  Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.

Authors:  Susan V Montgomery; Andrea M Barsevick; Brian L Egleston; Ruth Bingler; Karen Ruth; Suzanne M Miller; John Malick; Terrence P Cescon; Mary B Daly
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.